EQS-News: Agile Therapeutics, Inc.
NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

21.10.2022 / 17:00 CET/CEST
The issuer is solely responsible for the content of this announcement.


0.jpgContact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/


News Source: News Direct


21.10.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Agile Therapeutics, Inc.
United States
ISIN: US00847L2097
EQS News ID: 1469705

 
End of News EQS News Service

1469705  21.10.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1469705&application_name=news&site_id=boersennews